There is growing consensus that SBM may provide protective benefits to pigs experiencing disease challenges, especially in mid-late finishing phase of production.  Anecdotal and unpublished data suggest that limiting the levels of synthetic amino acids in disease-challenged pigs can result in improved growth and financial performance. The objective of these experiments was to confirm this benefit, increase SBM consumption and to improve the growth and feed efficiency performance of health challenged pigs, simultaneously.